Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. van de Loosdrecht, AA; Kalk, W; Bootsma, H; Henselmans, JML; Kraan, J; Kallenberg, CGM
   Simultaneous presentation of sarcoidosis and Sjogren's syndrome
   RHEUMATOLOGY
   
   A.A. van de Loosdrecht et al., "Simultaneous presentation of sarcoidosis and Sjogren's syndrome", RHEUMATOLOG, 40(1), 2001, pp. 113-115
2. Tervaert, JWC; Stegeman, CA; Kallenberg, CGM
   Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
   
   J.W.C. Tervaert et al., "Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis", CURR OP NEP, 10(2), 2001, pp. 211-217
3. Brons, RH; Kallenberg, CGM; Tervaert, JWC
   Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?
   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
   
   R.H. Brons et al., "Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?", RHEUM DIS C, 27(4), 2001, pp. 833
4. van der Geld, YM; Limburg, PC; Kallenberg, CGM
   Proteinase 3, Wegener's autoantigen: from gene to antigen
   JOURNAL OF LEUKOCYTE BIOLOGY
   
   Y.M. van der Geld et al., "Proteinase 3, Wegener's autoantigen: from gene to antigen", J LEUK BIOL, 69(2), 2001, pp. 177-190
5. Stegeman, CA; Kallenberg, CGM
   Clinical aspects of primary vasculitis
   SPRINGER SEMINARS IN IMMUNOPATHOLOGY
   
   C.A. Stegeman e C.G.M. Kallenberg, "Clinical aspects of primary vasculitis", SPR SEM IMM, 23(3), 2001, pp. 231-251
6. Limburg, PC; Kallenberg, CGM
   Antinuclear antibody screening in this new millennium: Farewell to the microscope? Comment on the article
   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
   
   P.C. Limburg e C.G.M. Kallenberg, "Antinuclear antibody screening in this new millennium: Farewell to the microscope? Comment on the article", SC J RHEUM, 30(3), 2001, pp. 127-128
7. Bijl, M; Limburg, PC; Kallenberg, CGM
   New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis
   NETHERLANDS JOURNAL OF MEDICINE
   
   M. Bijl et al., "New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis", NETH J MED, 59(2), 2001, pp. 66-75
8. van der Geld, YM; Simpelaar, A; van der Zee, R; Tervaert, JWC; Stegeman, CA; Limburg, PC; Kallenberg, CGM
   Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides
   KIDNEY INTERNATIONAL
   
   Y.M. van der Geld et al., "Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides", KIDNEY INT, 59(1), 2001, pp. 147-159
9. Heeringa, P; Bijl, M; de Jager-Krikken, A; Zandvoort, A; Dijkstra, G; Moshage, H; Tervaert, JWC; Tiebosch, ATMG; Kallenberg, CGM; van Goor, H
   Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis
   JOURNAL OF PATHOLOGY
   
   P. Heeringa et al., "Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis", J PATHOLOGY, 193(2), 2001, pp. 224-232
10. Boomsma, MM; Stegeman, CA; Oost-Kort, WW; Kallenberg, CGM; Moguilevsky, N; Limburg, PC; Tervaert, JWC
    Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis
    JOURNAL OF IMMUNOLOGICAL METHODS
    
    M.M. Boomsma et al., "Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis", J IMMUNOL M, 254(1-2), 2001, pp. 47-58
11. Bijl, M; Horst, G; Limburg, PC; Kallenberg, CGM
    Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    M. Bijl et al., "Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes", EUR J CL IN, 31(6), 2001, pp. 550-553
12. Bijl, M; Horst, G; Limburg, PC; Kallenberg, CGM
    Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    M. Bijl et al., "Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)", CLIN EXP IM, 123(1), 2001, pp. 127-132
13. Bijl, M; Horst, G; Limburg, PC; Kallenberg, CGM
    Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus
    ANNALS OF THE RHEUMATIC DISEASES
    
    M. Bijl et al., "Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus", ANN RHEUM D, 60(5), 2001, pp. 523-526
14. Brons, RH; de Jong, MCJM; de Boer, NK; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
    Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis
    ANNALS OF THE RHEUMATIC DISEASES
    
    R.H. Brons et al., "Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis", ANN RHEUM D, 60(12), 2001, pp. 1097-1102
15. Kalk, WWI; Vissink, A; Spijkervet, FKL; Bootsma, H; Kallenberg, CGM; Amerongen, AVN
    Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome
    ANNALS OF THE RHEUMATIC DISEASES
    
    W.W.I. Kalk et al., "Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome", ANN RHEUM D, 60(12), 2001, pp. 1110-1116
16. Eijkhout, HW; van der Meer, JWM; Kallenberg, CGM; Weening, RS; van Dissel, JT; Sanders, LAM; Strengers, PFW; Nienhuis, H; Schellekens, PTA
    The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial
    ANNALS OF INTERNAL MEDICINE
    
    H.W. Eijkhout et al., "The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial", ANN INT MED, 135(3), 2001, pp. 165-174
17. Hoekstra, PJ; Bijzet, J; Limburg, PC; Steenhuis, MP; Troost, PW; Oosterhoff, MD; Korf, J; Kallenberg, CGM; Minderaa, RB
    Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients
    AMERICAN JOURNAL OF PSYCHIATRY
    
    P.J. Hoekstra et al., "Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients", AM J PSYCHI, 158(4), 2001, pp. 605-610
18. Kallenberg, CGM; Tervaert, JWC
    New treatments of ANCA-associated vasculitis
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    
    C.G.M. Kallenberg e J.W.C. Tervaert, "New treatments of ANCA-associated vasculitis", SARCO VASC, 17(2), 2000, pp. 125-129
19. Hewins, P; Tervaert, JWC; Savage, COS; Kallenberg, CGM
    Is Wegener's granulomatosis an autoimmune disease?
    CURRENT OPINION IN RHEUMATOLOGY
    
    P. Hewins et al., "Is Wegener's granulomatosis an autoimmune disease?", CURR OP RH, 12(1), 2000, pp. 3-10
20. Kobold, ACM; Tulleken, JE; Zijlstra, JG; Sluiter, W; Hermans, J; Kallenberg, CGM; Tervaert, JWC
    Leukocyte activation in sepsis; correlations with disease state and mortality
    INTENSIVE CARE MEDICINE
    
    A.C.M. Kobold et al., "Leukocyte activation in sepsis; correlations with disease state and mortality", INTEN CAR M, 26(7), 2000, pp. 883-892
21. Roozendaal, C; de Jong, MA; van den Berg, AP; van Wijk, RT; Limburg, PC; Kallenberg, CGM
    Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases
    JOURNAL OF HEPATOLOGY
    
    C. Roozendaal et al., "Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases", J HEPATOL, 32(5), 2000, pp. 734-741
22. Franssen, CFM; Stegeman, CA; Kallenberg, CGM; Gans, ROB; de Jong, PE; Hoorntje, SJ; Tervaert, JWC
    Antiproteinase 3-and antimyeloperoxidase-associated vasculitis
    KIDNEY INTERNATIONAL
    
    C.F.M. Franssen et al., "Antiproteinase 3-and antimyeloperoxidase-associated vasculitis", KIDNEY INT, 57(6), 2000, pp. 2195-2206
23. Van der Geld, YM; Huitema, MG; Franssen, CFM; Van der Zee, R; Limburg, PC; Kallenberg, CGM
    In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    Y.M. Van der Geld et al., "In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)", CLIN EXP IM, 122(3), 2000, pp. 504-513
24. Brons, RH; Bakker, HI; Van Wijk, RT; Van Dijk, NW; Kobold, ACM; Limburg, PC; Manson, WL; Kallenberg, CGM; Tervaert, JWC
    Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    R.H. Brons et al., "Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?", CLIN EXP IM, 119(3), 2000, pp. 566-573
25. Boomsma, MM; Stegeman, CA; van der Leij, MJ; Oost, W; Hermans, J; Kallenberg, CGM; Limburg, PC; Tervaert, JWC
    Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels - A prospective study
    ARTHRITIS AND RHEUMATISM
    
    M.M. Boomsma et al., "Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels - A prospective study", ARTH RHEUM, 43(9), 2000, pp. 2025-2033
26. Dijstelbloem, HM; Bijl, M; Fijnheer, R; Scheepers, RHM; Oost, WW; Jansen, MD; Sluiter, WJ; Limburg, PC; Derksen, RHWM; van de Winkel, JGJ; Kallenberg, CGM
    Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes
    ARTHRITIS AND RHEUMATISM
    
    H.M. Dijstelbloem et al., "Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes", ARTH RHEUM, 43(12), 2000, pp. 2793-2800
27. Heeringa, P; van Goor, H; Itoh-Lindstrom, Y; Maeda, N; Falk, RJ; Assmann, KJM; Kallenberg, CGM; Jennette, JC
    Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis
    AMERICAN JOURNAL OF PATHOLOGY
    
    P. Heeringa et al., "Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis", AM J PATH, 156(3), 2000, pp. 879-888
28. Roozendaal, C; Pogany, K; Hummel, EJ; Horst, G; Dijkstra, G; Nelis, GF; Limburg, PC; Kleibeuker, JH; Kallenberg, CGM
    Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    C. Roozendaal et al., "Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity", QJM-MON J A, 92(11), 1999, pp. 651-658
29. Foucher, P; Heeringa, P; Petersen, AH; Huitema, MG; Brouwer, E; Tervaert, JWC; Prop, J; Camus, P; Weening, FJ; Kallenberg, CGM
    Antimyeloperoxidase-associated lung disease - An experimental model
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    P. Foucher et al., "Antimyeloperoxidase-associated lung disease - An experimental model", AM J R CRIT, 160(3), 1999, pp. 987-994
30. Franssen, CFM; Huitema, MG; Kobold, ACM; Oost-Kort, WW; Limburg, PC; Tiebosch, A; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
    In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    C.F.M. Franssen et al., "In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis", J AM S NEPH, 10(7), 1999, pp. 1506-1515
31. Kobold, ACM; van Wijk, RT; Franssen, CFM; Molema, G; Kallenberg, CGM; Tervaert, JWC
    In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    A.C.M. Kobold et al., "In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis", CLIN EXP RH, 17(4), 1999, pp. 433-440
32. van Lopik, T; Bijl, M; Hart, M; Boeije, L; Gesner, T; Creasy, AA; Kallenberg, CGM; Aarden, LA; Smeenk, RJT; Smeenk, JT
    Patients with systemic lupus erythematosus with high plasma levels of sFasrisk relapse
    JOURNAL OF RHEUMATOLOGY
    
    T. van Lopik et al., "Patients with systemic lupus erythematosus with high plasma levels of sFasrisk relapse", J RHEUMATOL, 26(1), 1999, pp. 60-67
33. Haveman, JW; Kobold, ACM; Tervaert, JWC; van den Berg, AP; Tulleken, JE; Kallenberg, CGM; The, TH
    The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment
    NETHERLANDS JOURNAL OF MEDICINE
    
    J.W. Haveman et al., "The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment", NETH J MED, 55(3), 1999, pp. 132-141
34. Roozendaal, C; Kallenberg, CGM
    Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases
    HEPATO-GASTROENTEROLOGY
    
    C. Roozendaal e C.G.M. Kallenberg, "Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases", HEP-GASTRO, 46(30), 1999, pp. 3034-3040
35. Popa, ER; Stegeman, CA; Bos, NA; Kallenberg, CGM; Tervaert, JWC
    Differential B- and T-cell activation in Wegener's granulomatosis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    E.R. Popa et al., "Differential B- and T-cell activation in Wegener's granulomatosis", J ALLERG CL, 103(5), 1999, pp. 885-894
36. Roozendaal, C; Pogany, K; Horst, G; Jagt, TG; Kleibeuker, JH; Nelis, GF; Limburg, PC; Kallenberg, CGM
    Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    C. Roozendaal et al., "Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?", SC J GASTR, 34(11), 1999, pp. 1123-1131
37. de Jong, BM; Pruim, J; Sinnige, LGF; Beintema, KD; Spronk, PE; Bootsma, H; Kallenberg, CGM; van Zomeren, AH; Haaxma-Reiche, H
    Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography
    EUROPEAN NEUROLOGY
    
    B.M. de Jong et al., "Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography", EUR NEUROL, 41(4), 1999, pp. 187-193
38. Van Der Geld, YM; Limburg, PC; Kallenberg, CGM
    Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    Y.M. Van Der Geld et al., "Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies", CLIN EXP IM, 118(3), 1999, pp. 487-496
39. Roozendaal, C; Kallenberg, CGM
    Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    C. Roozendaal e C.G.M. Kallenberg, "Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?", CLIN EXP IM, 116(2), 1999, pp. 206-213
40. Dijstelbloem, HM; Scheepers, RHM; Oost, WW; Stegeman, CA; van der Pol, WL; Sluiter, WJ; Kallenberg, CGM; van de Winkel, JGJ; Tervaert, JWC
    Fc gamma receptor polymorphisms in Wegener's granulomatosis - Risk factorsfor disease relapse
    ARTHRITIS AND RHEUMATISM
    
    H.M. Dijstelbloem et al., "Fc gamma receptor polymorphisms in Wegener's granulomatosis - Risk factorsfor disease relapse", ARTH RHEUM, 42(9), 1999, pp. 1823-1827
41. Kallenberg, CGM; Heeringa, P; Tervaert, JWC
    Are antineutrophil cytoplasmic antibodies pathogenic in wegener's granulomatosis? Lessons from in vitro and in vivo experimental findings
    DECADE OF AUTOIMMUNITY
    
    C.G.M. Kallenberg et al., "Are antineutrophil cytoplasmic antibodies pathogenic in wegener's granulomatosis? Lessons from in vitro and in vivo experimental findings", DECADE OF AUTOIMMUNITY, 1999, pp. 227-234
42. SPRONK PE; BOOTSMA H; KALLENBERG CGM
    ANTI-DNA ANTIBODIES AS EARLY PREDICTOR FOR DISEASE EXACERBATIONS IN SLE - GUIDELINE FOR TREATMENT
    Clinical reviews in allergy and immunology
    
    P.E. Spronk et al., "ANTI-DNA ANTIBODIES AS EARLY PREDICTOR FOR DISEASE EXACERBATIONS IN SLE - GUIDELINE FOR TREATMENT", Clinical reviews in allergy and immunology, 16(3), 1998, pp. 211-218
43. FRANSSEN CFM; STEGEMAN CA; OOSTKORT WW; KALLENBERG CGM; LIMBURG PC; TIEBOSCH A; DEJONG PE; TERVAERT JWC
    DETERMINANTS OF RENAL OUTCOME IN ANTI-MYELOPEROXIDASE-ASSOCIATED NECROTIZING CRESCENTIC GLOMERULONEPHRITIS
    Journal of the American Society of Nephrology
    
    C.F.M. Franssen et al., "DETERMINANTS OF RENAL OUTCOME IN ANTI-MYELOPEROXIDASE-ASSOCIATED NECROTIZING CRESCENTIC GLOMERULONEPHRITIS", Journal of the American Society of Nephrology, 9(10), 1998, pp. 1915-1923
44. KALLENBERG CGM; HEERINGA P
    PATHOGENESIS OF VASCULITIS
    Lupus
    
    C.G.M. Kallenberg e P. Heeringa, "PATHOGENESIS OF VASCULITIS", Lupus, 7(4), 1998, pp. 280-284
45. KALLENBERG CGM
    AUTOANTIBODIES TO MYELOPEROXIDASE - CLINICAL AND PATHOPHYSIOLOGICAL SIGNIFICANCE
    Journal of molecular medicine
    
    C.G.M. Kallenberg, "AUTOANTIBODIES TO MYELOPEROXIDASE - CLINICAL AND PATHOPHYSIOLOGICAL SIGNIFICANCE", Journal of molecular medicine, 76(10), 1998, pp. 682-687
46. TERVAERT JWC; STEGEMAN CA; MANSON WL; KALLENBERG CGM; JOHNSON WM
    STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)
    The FASEB journal
    
    J.W.C. Tervaert et al., "STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)", The FASEB journal, 12(4), 1998, pp. 2835-2835
47. KOBOLD ACM; KALLENBERG CGM; TERVAERT JWC
    LEUKOCYTE MEMBRANE EXPRESSION OF PROTEINASE-3 CORRELATES WITH DISEASE-ACTIVITY IN PATIENTS WITH WEGENERS GRANULOMATOSIS
    British journal of rheumatology (Print)
    
    A.C.M. Kobold et al., "LEUKOCYTE MEMBRANE EXPRESSION OF PROTEINASE-3 CORRELATES WITH DISEASE-ACTIVITY IN PATIENTS WITH WEGENERS GRANULOMATOSIS", British journal of rheumatology (Print), 37(8), 1998, pp. 901-907
48. HEERINGA P; BROUWER E; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
    ANIMAL-MODELS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS
    Kidney international
    
    P. Heeringa et al., "ANIMAL-MODELS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS", Kidney international, 53(2), 1998, pp. 253-263
49. HEERINGA P; VANGOOR H; MOSHAGE H; KLOK PA; HUITEMA MG; DEJAGER A; SCHEP AJ; KALLENBERG CGM
    EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE-MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS
    Kidney international
    
    P. Heeringa et al., "EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE-MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS", Kidney international, 53(2), 1998, pp. 382-393
50. ROOZENDAAL C; DEWIT AWMV; HAAGSMA EB; HORST G; SCHWARZE C; PETER HH; KLEIBEUKER JH; TERVAERT JWC; LIMBURG PC; KALLENBERG CGM
    ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - TARGET ANTIGENS AND CLINICAL ASSOCIATIONS
    Gastroenterology
    
    C. Roozendaal et al., "ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - TARGET ANTIGENS AND CLINICAL ASSOCIATIONS", Gastroenterology, 114(4), 1998, pp. 535-535
51. ROOZENDAAL C; HUMMEL EJ; DEJONG MA; KLEIBEUKER JH; VANDENBERG AP; LIMBURG PC; KALLENBERG CGM
    ANTIBODIES AGAINST MONOCYTES IN INFLAMMATORY BOWEL AND AUTOIMMUNE LIVER-DISEASES
    Gastroenterology
    
    C. Roozendaal et al., "ANTIBODIES AGAINST MONOCYTES IN INFLAMMATORY BOWEL AND AUTOIMMUNE LIVER-DISEASES", Gastroenterology, 114(4), 1998, pp. 4386-4386
52. ROOZENDAAL C; ZHAO MH; HORST G; LOCKWOOD CM; KLEIBEUKER JH; LIMBURG PC; NELIS GF; KALLENBERG CGM
    CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL DISEASES
    Gastroenterology
    
    C. Roozendaal et al., "CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL DISEASES", Gastroenterology, 114(4), 1998, pp. 4387-4387
53. KOBOLD ACM; ZIJLSTRA JG; KOENE HR; DEHAAS M; KALLENBERG CGM; TERVAERT JWC
    LEVELS OF SOLUBLE FC-GAMMA-RIII CORRELATE WITH DISEASE SEVERITY IN SEPSIS
    Clinical and experimental immunology
    
    A.C.M. Kobold et al., "LEVELS OF SOLUBLE FC-GAMMA-RIII CORRELATE WITH DISEASE SEVERITY IN SEPSIS", Clinical and experimental immunology, 114(2), 1998, pp. 220-227
54. ROOZENDAAL C; ZHAO MH; HORST G; LOCKWOOD CM; KLEIBEUKER JH; LIMBURG PC; NELIS GF; KALLENBERG CGM
    CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL-DISEASE (IBD)
    Clinical and experimental immunology
    
    C. Roozendaal et al., "CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL-DISEASE (IBD)", Clinical and experimental immunology, 112(1), 1998, pp. 10-16
55. Kobold, ACM; Mesander, G; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
    Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    A.C.M. Kobold et al., "Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?", CLIN EXP IM, 114(3), 1998, pp. 491-499
56. KOENE HR; KLEIJER M; SWAAK AJG; SULLIVAN KE; BIJL M; PETRI MA; KALLENBERG CGM; ROOS D; VONDEMBORNE AEGK; DEHAAS M
    THE FC-GAMMA-RIIIA-158F ALLELE IS A RISK FACTOR FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    Arthritis and rheumatism
    
    H.R. Koene et al., "THE FC-GAMMA-RIIIA-158F ALLELE IS A RISK FACTOR FOR SYSTEMIC LUPUS-ERYTHEMATOSUS", Arthritis and rheumatism, 41(10), 1998, pp. 1813-1818
57. ROOZENDAAL C; VANMILLEGENDEWIT AWM; HAAGSMA EB; HORST G; SCHWARZE C; PETER HH; KLEIBEUKER JH; TERVAERT JWC; LIMBURG PC; KALLENBERG CGM
    ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - DEFINED SPECIFICITIES MAY BE ASSOCIATED WITH DISTINCT CLINICAL-FEATURES
    The American journal of medicine
    
    C. Roozendaal et al., "ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - DEFINED SPECIFICITIES MAY BE ASSOCIATED WITH DISTINCT CLINICAL-FEATURES", The American journal of medicine, 105(5), 1998, pp. 393-399
58. GEORGE J; LEVY Y; KALLENBERG CGM; SHOENFELD Y
    INFECTIONS AND WEGENERS GRANULOMATOSIS - A CAUSE AND EFFECT RELATIONSHIP
    Quarterly Journal of Medicine
    
    J. George et al., "INFECTIONS AND WEGENERS GRANULOMATOSIS - A CAUSE AND EFFECT RELATIONSHIP", Quarterly Journal of Medicine, 90(5), 1997, pp. 367-373
59. KALLENBERG CGM
    VASCULITIS AND THE KIDNEY
    Kidney & blood pressure research
    
    C.G.M. Kallenberg, "VASCULITIS AND THE KIDNEY", Kidney & blood pressure research, 20(3), 1997, pp. 194-197
60. TERVAERT JWC; STEGEMAN CA; MANSON WL; KALLENBERG CGM; JOHNSON WM
    STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)
    Journal of the American Society of Nephrology
    
    J.W.C. Tervaert et al., "STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)", Journal of the American Society of Nephrology, 8, 1997, pp. 2482-2482
61. FRANSSEN CFM; STEGEMAN CA; DEJONG PE; KALLENBERG CGM; TERVAERT JWC
    KIDNEY SURVIVAL IN PATIENTS WITH ANTIMYELOPEROXIDASE (MPO) ASSOCIATEDGLOMERULONEPHRITIS (GN) IS RELATED TO THE SEVERITY OF PROTEINURIA
    Journal of the American Society of Nephrology
    
    C.F.M. Franssen et al., "KIDNEY SURVIVAL IN PATIENTS WITH ANTIMYELOPEROXIDASE (MPO) ASSOCIATEDGLOMERULONEPHRITIS (GN) IS RELATED TO THE SEVERITY OF PROTEINURIA", Journal of the American Society of Nephrology, 8, 1997, pp. 2488-2488
62. POPA ER; BOS NA; STEGEMAN CA; KALLENBERG CGM; TERVAERT JWC
    SKEWED TCR V-BETA USAGE IN WEGENERS GRANULOMATOSIS SUGGESTS STIMULATION BY SUPERANTIGENS
    Journal of the American Society of Nephrology
    
    E.R. Popa et al., "SKEWED TCR V-BETA USAGE IN WEGENERS GRANULOMATOSIS SUGGESTS STIMULATION BY SUPERANTIGENS", Journal of the American Society of Nephrology, 8, 1997, pp. 2528-2528
63. POPA ER; STEGEMAN CA; BOS NA; KALLENBERG CGM; TERVAERT JWC
    T-LYMPHOCYTE BUT NOT BETA-LYMPHOCYTE ACTIVATION IN WEGENERS GRANULOMATOSIS PERSISTS DURING REMISSION
    Journal of the American Society of Nephrology
    
    E.R. Popa et al., "T-LYMPHOCYTE BUT NOT BETA-LYMPHOCYTE ACTIVATION IN WEGENERS GRANULOMATOSIS PERSISTS DURING REMISSION", Journal of the American Society of Nephrology, 8, 1997, pp. 2529-2529
64. KALLENBERG CGM
    LABORATORY FINDINGS IN THE VASCULITIDES
    Bailliere's clinical rheumatology
    
    C.G.M. Kallenberg, "LABORATORY FINDINGS IN THE VASCULITIDES", Bailliere's clinical rheumatology, 11(2), 1997, pp. 395-421
65. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
    COTRIMOXAZOLE AND WEGENERS GRANULOMATOSIS - MORE THAN A COINCIDENCE
    Nephrology, dialysis, transplantation
    
    C.A. Stegeman et al., "COTRIMOXAZOLE AND WEGENERS GRANULOMATOSIS - MORE THAN A COINCIDENCE", Nephrology, dialysis, transplantation, 12(4), 1997, pp. 652-655
66. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
    SULFONAMIDES IN VASCULITIDES - WHICH MECHANISM - REPLY
    Nephrology, dialysis, transplantation
    
    C.A. Stegeman et al., "SULFONAMIDES IN VASCULITIDES - WHICH MECHANISM - REPLY", Nephrology, dialysis, transplantation, 12(11), 1997, pp. 2462-2463
67. VANBRUGGEN MCJ; KRAMERS C; WALGREEN B; ELEMA JD; KALLENBERG CGM; VANDENBORN J; SMEENK RJT; ASSMANN KJM; MULLER S; MONESTIER M; BERDEN JHM
    NUCLEOSOMES AND HISTONES ARE PRESENT IN GLOMERULAR DEPOSITS IN HUMAN LUPUS NEPHRITIS
    Nephrology, dialysis, transplantation
    
    M.C.J. Vanbruggen et al., "NUCLEOSOMES AND HISTONES ARE PRESENT IN GLOMERULAR DEPOSITS IN HUMAN LUPUS NEPHRITIS", Nephrology, dialysis, transplantation, 12(1), 1997, pp. 57-66
68. HEERINGA P; VANGOOR H; MOSHAGE H; KLOK PA; KALLENBERG CGM
    EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS (NCGN)
    Kidney international
    
    P. Heeringa et al., "EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS (NCGN)", Kidney international, 52(2), 1997, pp. 571-572
69. FRANSSEN CFM; STEGEMAN CA; OOSTKORT W; KALLENBERG CGM; COHEN JW
    PERSISTENTLY HIGH-LEVELS OF ANTIBODIES AGAINST MYELOPEROXIDASE (MPO) ARE PREDICTIVE OF POOR OUTCOME IN PATIENTS WITH ANTI-MPO ASSOCIATED GLOMERULONEPHRITIS
    Kidney international
    
    C.F.M. Franssen et al., "PERSISTENTLY HIGH-LEVELS OF ANTIBODIES AGAINST MYELOPEROXIDASE (MPO) ARE PREDICTIVE OF POOR OUTCOME IN PATIENTS WITH ANTI-MPO ASSOCIATED GLOMERULONEPHRITIS", Kidney international, 52(2), 1997, pp. 572-572
70. JAYNE DRW; RASMUSSEN N; ABRAMOWICZ D; TESAR V; RASMUSSEN N; PETERSEN J; JUHL BR; WIIK A; GRONHAGENRISKA C; GUILLEVIN L; LHOTE F; LANDAIS P; LESAVRE P; VANHILLE P; ANDRASSY K; DEGROOT K; GROSS WL; VANDERWOUDE F; BOKI KA; TERVAERT JWC; KALLENBERG CGM; VANES LA; HERMANS J; SIEGERT C; HAGEN EC; FEIGHERY CF; GREGORINI G; FERRARIO F; SINICO RA; DADONIENE J; VASCONCELOS C; MIRAPEIX E; HEIGL Z; PETTERSSON EE; WESTMAN KWA; BACON PA; SAVAGE COS; JAYNE DRW; LOCKWOOD CM; LUQMANI RA; GASKIN G; PUSEY CD; SPECKS U
    TREATMENT OF ANTINEUTROPHIL CYTOPLASM AUTOANTIBODY-ASSOCIATED SYSTEMIC VASCULITIS - INITIATIVES OF THE EUROPEAN-COMMUNITY SYSTEMIC VASCULITIS CLINICAL-TRIALS STUDY-GROUP
    Mayo Clinic proceedings
    
    D.R.W. Jayne et al., "TREATMENT OF ANTINEUTROPHIL CYTOPLASM AUTOANTIBODY-ASSOCIATED SYSTEMIC VASCULITIS - INITIATIVES OF THE EUROPEAN-COMMUNITY SYSTEMIC VASCULITIS CLINICAL-TRIALS STUDY-GROUP", Mayo Clinic proceedings, 72(8), 1997, pp. 737-747
71. KALLENBERG CGM
    ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AND THE ENDOTHELIUM - MANY WAYSTO VASCULITIS
    European journal of clinical investigation
    
    C.G.M. Kallenberg, "ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AND THE ENDOTHELIUM - MANY WAYSTO VASCULITIS", European journal of clinical investigation, 27(11), 1997, pp. 900-901
72. HARMSEN MC; HEERINGA P; VANDERGELD YM; HUITEMA MG; KLIMP A; TIRAN A; KALLENBERG CGM
    RECOMBINANT PROTEINASE-3 (WREGENERS ANTIGEN) EXPRESSED IN PICHIA-PASTORIS IS FUNCTIONALLY ACTIVE AND IS RECOGNIZED BY PATIENT SERA
    Clinical and experimental immunology
    
    M.C. Harmsen et al., "RECOMBINANT PROTEINASE-3 (WREGENERS ANTIGEN) EXPRESSED IN PICHIA-PASTORIS IS FUNCTIONALLY ACTIVE AND IS RECOGNIZED BY PATIENT SERA", Clinical and experimental immunology, 110(2), 1997, pp. 257-264
73. KOENE HR; KLEIJER M; SWAAK AJG; SULLIVAN KE; BIJL M; PETRI MA; KALLENBERG CGM; ROOS D; VONDEMBORNE AEGK; DEHAAS M
    THE FC-GAMMA-RIIIA-158F IS A RISK FACTOR FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    Blood
    
    H.R. Koene et al., "THE FC-GAMMA-RIIIA-158F IS A RISK FACTOR FOR SYSTEMIC LUPUS-ERYTHEMATOSUS", Blood, 90(10), 1997, pp. 2891-2891
74. BOOTSMA H; DERKSEN RHWM; JAEGERS SMHJ; SPRONK PE; BIJL M; KATER L; KALLENBERG CGM
    USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/
    Arthritis and rheumatism
    
    H. Bootsma et al., "USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/", Arthritis and rheumatism, 40(9), 1997, pp. 775-775
75. BILL M; VANLOPIK T; LIMBURG PC; AARDEN LA; SMEENK RJT; KALLENBERG CGM
    FLUCTUATING LEVELS OF SERUM-SOLUBLE FAS IN RELATION TO DISEASE-ACTIVITY AND LYMPHOCYTE-ACTIVATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Arthritis and rheumatism
    
    M. Bill et al., "FLUCTUATING LEVELS OF SERUM-SOLUBLE FAS IN RELATION TO DISEASE-ACTIVITY AND LYMPHOCYTE-ACTIVATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Arthritis and rheumatism, 40(9), 1997, pp. 885-885
76. KALLENBERG CGM; BOOTSMA H; SPRONK PE; TERBORG EJ; DERKSEN RHWM; KATER L
    LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT
    Arthritis and rheumatism
    
    C.G.M. Kallenberg et al., "LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT", Arthritis and rheumatism, 40(2), 1997, pp. 393-393
77. BOOTSMA H; SPRONK PE; TERBORG EJ; HUMMEL EJ; DEBOER G; LIMBURG PC; KALLENBERG CGM
    THE PREDICTIVE VALUE OF FLUCTUATIONS IN IGM AND IGG CLASS ANTI-DSDNA ANTIBODIES FOR RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE LONG-TERM OBSERVATION
    Annals of the Rheumatic Diseases
    
    H. Bootsma et al., "THE PREDICTIVE VALUE OF FLUCTUATIONS IN IGM AND IGG CLASS ANTI-DSDNA ANTIBODIES FOR RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE LONG-TERM OBSERVATION", Annals of the Rheumatic Diseases, 56(11), 1997, pp. 661-666
78. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
    SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT
    The American journal of pathology
    
    P. Heeringa et al., "SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT", The American journal of pathology, 151(1), 1997, pp. 131-140
79. TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
    SERIAL ANCA TESTING IS USEFUL IN MONITORING DISEASE-ACTIVITY OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES
    Sarcoidosis vasculitis and diffuse lung diseases
    
    J.W.C. Tervaert et al., "SERIAL ANCA TESTING IS USEFUL IN MONITORING DISEASE-ACTIVITY OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES", Sarcoidosis vasculitis and diffuse lung diseases, 13(3), 1996, pp. 241-245
80. KALLENBERG CGM; STEGEMAN CA; TERVAERT JWC
    STAPHYLOCOCCUS-AUREUS, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND WEGENERS GRANULOMATOSIS
    Sarcoidosis vasculitis and diffuse lung diseases
    
    C.G.M. Kallenberg et al., "STAPHYLOCOCCUS-AUREUS, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND WEGENERS GRANULOMATOSIS", Sarcoidosis vasculitis and diffuse lung diseases, 13(3), 1996, pp. 253-255
81. HEERINGA P; KLOK PA; HUITEMA MG; VANDENBORN J; WEENING JJ; KALLENBERG CGM
    AUTOANTIBODIES TO MYELOPEROXIDASE AGGRAVATE MILD IMMUNE-MEDIATED GLOMERULAR INJURY IN THE RAT
    Journal of the American Society of Nephrology
    
    P. Heeringa et al., "AUTOANTIBODIES TO MYELOPEROXIDASE AGGRAVATE MILD IMMUNE-MEDIATED GLOMERULAR INJURY IN THE RAT", Journal of the American Society of Nephrology, 7(9), 1996, pp. 2279-2279
82. HEERINGA P; VANGOOR H; MOSHAGE H; KALLENBERG CGM
    EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE MODIFIED PROTEINS IN EXPERIMENTAL ANTI MYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS
    Journal of the American Society of Nephrology
    
    P. Heeringa et al., "EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE MODIFIED PROTEINS IN EXPERIMENTAL ANTI MYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS", Journal of the American Society of Nephrology, 7(9), 1996, pp. 2434-2434
83. FRANSSEN CFM; STEGEMAN CA; OOSTKORT WW; KALLENBERG CGM; TERVAERT JWC
    PROGNOSTIC FACTORS IN ANTIMYELOPEROXIDASE (MPO) ASSOCIATED GLOMERULONEPHRITIS (GN)
    Journal of the American Society of Nephrology
    
    C.F.M. Franssen et al., "PROGNOSTIC FACTORS IN ANTIMYELOPEROXIDASE (MPO) ASSOCIATED GLOMERULONEPHRITIS (GN)", Journal of the American Society of Nephrology, 7(9), 1996, pp. 2631-2631
84. TERVAERT JWC; BAKKER HI; GJALTEMAVANBUITEN L; HEERINGA P; MANSON WL; KALLENBERG CGM
    STAPHYLOCOCCAL ACID-PHOSPHATASE BINDS TO CULTURED ENDOTHELIAL-CELLS AND TO THE GLOMERULAR CAPILLARY WALL IN-VIVO
    Journal of the American Society of Nephrology
    
    J.W.C. Tervaert et al., "STAPHYLOCOCCAL ACID-PHOSPHATASE BINDS TO CULTURED ENDOTHELIAL-CELLS AND TO THE GLOMERULAR CAPILLARY WALL IN-VIVO", Journal of the American Society of Nephrology, 7(9), 1996, pp. 2681-2681
85. KOBOLD ACM; MESANDER G; KALLENBERG CGM; TERVAERT JWC
    INCREASED EXPRESSION OF LEUKOCYTE ADHESION MOLECULES ON CIRCULATING LEUKOCYTES IN ANTINEUTROPHIL CYTOPLASMIC ASSOCIATED (ANCA) VASCULITIS
    The FASEB journal
    
    A.C.M. Kobold et al., "INCREASED EXPRESSION OF LEUKOCYTE ADHESION MOLECULES ON CIRCULATING LEUKOCYTES IN ANTINEUTROPHIL CYTOPLASMIC ASSOCIATED (ANCA) VASCULITIS", The FASEB journal, 10(6), 1996, pp. 1641-1641
86. KALLENBERG CGM
    TREATMENT OF WEGENER GRANULOMATOSIS - NEW HORIZONS
    Clinical and experimental rheumatology
    
    C.G.M. Kallenberg, "TREATMENT OF WEGENER GRANULOMATOSIS - NEW HORIZONS", Clinical and experimental rheumatology, 14(1), 1996, pp. 1-4
87. BOOTSMA H; SPRONK PE; HUMMEL EJ; DEBOER G; TERBORG EJ; LIMBURG PC; KALLENBERG CGM
    ANTI-DOUBLE STRANDED DNA ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS -DETECTION AND CLINICAL RELEVANCE OF IGM-CLASS ANTIBODIES
    Scandinavian journal of rheumatology
    
    H. Bootsma et al., "ANTI-DOUBLE STRANDED DNA ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS -DETECTION AND CLINICAL RELEVANCE OF IGM-CLASS ANTIBODIES", Scandinavian journal of rheumatology, 25(6), 1996, pp. 352-359
88. SPRONK PE; BOOTSMA H; HORST G; HUITEMA MG; LIMBURG PC; TERVAERT JWC; KALLENBERG CGM
    ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    British journal of rheumatology
    
    P.E. Spronk et al., "ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS", British journal of rheumatology, 35(7), 1996, pp. 625-631
89. DEJONG BM; PRUIM J; SINNIGE LGF; BEINTEMA KD; KALLENBERG CGM; HAAXMAREICHE H
    EVIDENCE FOR REDUCED PREMOTOR CORTEX METABOLISM AND INCREASED BASAL GANGLIA FLUORODEOXYGLUCOSE (FDG) UPTAKE IN CEREBRAL SYSTEMIC LUPUS
    The Journal of nuclear medicine
    
    B.M. Dejong et al., "EVIDENCE FOR REDUCED PREMOTOR CORTEX METABOLISM AND INCREASED BASAL GANGLIA FLUORODEOXYGLUCOSE (FDG) UPTAKE IN CEREBRAL SYSTEMIC LUPUS", The Journal of nuclear medicine, 37(5), 1996, pp. 75-75
90. FRANSSEN CFM; TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
    C-ANCA AS A MARKER OF WEGENERS DISEASE
    Lancet
    
    C.F.M. Franssen et al., "C-ANCA AS A MARKER OF WEGENERS DISEASE", Lancet, 347(8994), 1996, pp. 116-116
91. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
    COTRIMOXAZOLE IN WEGENERS GRANULOMATOSIS - REPLY
    The New England journal of medicine
    
    C.A. Stegeman et al., "COTRIMOXAZOLE IN WEGENERS GRANULOMATOSIS - REPLY", The New England journal of medicine, 335(23), 1996, pp. 1770-1770
92. STEGEMAN CA; TERVAERT JWC; DEJONG PE; KALLENBERG CGM
    TRIMETHOPRIM-SULFAMETHOXAZOLE (COTRIMOXAZOLE) FOR THE PREVENTION OF RELAPSES OF WEGENERS GRANULOMATOSIS
    The New England journal of medicine
    
    C.A. Stegeman et al., "TRIMETHOPRIM-SULFAMETHOXAZOLE (COTRIMOXAZOLE) FOR THE PREVENTION OF RELAPSES OF WEGENERS GRANULOMATOSIS", The New England journal of medicine, 335(1), 1996, pp. 16-20
93. HAGEN EC; ANDRASSY K; CSERNOK E; DAHA MR; GASKIN G; GROSS WL; HANSEN B; HEIGL Z; HERMANS J; JAYNE D; KALLENBERG CGM; LESAVRE P; LOCKWOOD CM; LUDEMANN J; MASCARTLEMONE F; MIRAPEIX E; PUSEY CD; RASMUSSEN N; SINICO RA; TZIOUFAS A; WIESLANDER J; WIIK A; VANDERWOUDE FJ
    DEVELOPMENT AND STANDARDIZATION OF SOLID-PHASE ASSAYS FOR THE DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - A REPORT ON THE 2ND-PHASE OF AN INTERNATIONAL COOPERATIVE STUDY ON THE STANDARDIZATION OF ANCA ASSAYS
    Journal of immunological methods
    
    E.C. Hagen et al., "DEVELOPMENT AND STANDARDIZATION OF SOLID-PHASE ASSAYS FOR THE DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - A REPORT ON THE 2ND-PHASE OF AN INTERNATIONAL COOPERATIVE STUDY ON THE STANDARDIZATION OF ANCA ASSAYS", Journal of immunological methods, 196(1), 1996, pp. 1-15
94. KALLENBERG CGM
    VASCULITIS 1995 - NEW CONCEPTS IN PATHOPHYSIOLOGY
    Israel journal of medical sciences
    
    C.G.M. Kallenberg, "VASCULITIS 1995 - NEW CONCEPTS IN PATHOPHYSIOLOGY", Israel journal of medical sciences, 32(1), 1996, pp. 7-12
95. ROOZENDAAL C; HORST G; POGANY K; BROEKROELOFS J; KLEIBEUKER JH; NELIS GF; LIMBURG PC; KALLENBERG CGM
    PREVALENCE AND CHARACTERIZATION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN INFLAMMATORY BOWEL DISEASES
    Gastroenterology
    
    C. Roozendaal et al., "PREVALENCE AND CHARACTERIZATION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN INFLAMMATORY BOWEL DISEASES", Gastroenterology, 110(4), 1996, pp. 1003-1003
96. HEERINGA P; VANDENBORN J; BROUWER E; DOLMAN KM; KLOK PA; HUITEMA MG; LIMBURG PC; BAKKER MAH; BERDEN JHM; DAHA MR; KALLENBERG CGM
    ELASTASE, BUT NOT PROTEINASE-3 (PR3), INDUCES PROTEINURIA ASSOCIATED WITH LOSS OF GLOMERULAR-BASEMENT-MEMBRANE HEPARAN-SULFATE AFTER IN-VIVO RENAL PERFUSION IN RATS
    Clinical and experimental immunology
    
    P. Heeringa et al., "ELASTASE, BUT NOT PROTEINASE-3 (PR3), INDUCES PROTEINURIA ASSOCIATED WITH LOSS OF GLOMERULAR-BASEMENT-MEMBRANE HEPARAN-SULFATE AFTER IN-VIVO RENAL PERFUSION IN RATS", Clinical and experimental immunology, 105(2), 1996, pp. 321-329
97. SPRONK PE; HORST G; VANDERGUN BTF; LIMBURG PC; KALLENBERG CGM
    ANTI-DSDNA PRODUCTION COINCIDES WITH CONCURRENT B-CELL AND T-CELL ACTIVATION DURING DEVELOPMENT OF ACTIVE DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    Clinical and experimental immunology
    
    P.E. Spronk et al., "ANTI-DSDNA PRODUCTION COINCIDES WITH CONCURRENT B-CELL AND T-CELL ACTIVATION DURING DEVELOPMENT OF ACTIVE DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)", Clinical and experimental immunology, 104(3), 1996, pp. 446-453
98. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; KALLENBERG CGM
    SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS
    Arthritis and rheumatism
    
    P. Heeringa et al., "SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS", Arthritis and rheumatism, 39(9), 1996, pp. 85-85
99. BOOTSMA H; SPRONK PE; LIMBURG PC; MEYLING FHJG; KATER L; DERKSEN RHWM; KALLENBERG CGM
    COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY
    Arthritis and rheumatism
    
    H. Bootsma et al., "COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY", Arthritis and rheumatism, 39(9), 1996, pp. 261-261
100. KRAMERS C; VANBRUGGEN MCJ; WALGREEN B; ELEMA JD; KALLENBERG CGM; VANDEBORN J; ASSMANN KJM; MULLER S; MONESTIER M; BERDEN JHM
     NUCLEOSOMES AND HISTONES ARE PRESENT IN GLOMERULAR DEPOSITS IN HUMAN LUPUS NEPHRITIS
     Journal of the American Society of Nephrology
     
     C. Kramers et al., "NUCLEOSOMES AND HISTONES ARE PRESENT IN GLOMERULAR DEPOSITS IN HUMAN LUPUS NEPHRITIS", Journal of the American Society of Nephrology, 6(3), 1995, pp. 425-425